PURE Bioscience reports fiscal Q1 2026 revenue up 27% to $707K, net loss narrows to $464K

PURE BIOSCIENCE, INC.

2026-Q1 EPS reported $0.00 revenue$707,000

Net product sales $707K for Q1 ended Oct 31, 2025, up 27% from $555K YoY.
Net loss $464K vs $689K year ago; net loss per share ($0.00) vs ($0.01).
Adjusted net loss (excl. share-based comp) was $430K vs $632K.
PURE Control now treating leafy greens for commercial sale; traction in transportation with SDC-powered sanitation.
Working with distribution partners in beverage and dairy to roll out membrane treatment solutions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.